[Bumadizone-calcium-semihydrate (Eumotol) and oxyphenbutazone in the treatment of ankylosing spondylitis. A clinical double-blind study].
D000328:Adult; D000368:Aged; D001799:Blood Sedimentation; D002118:Calcium; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D008297:Male; D008314:Malonates / Q000009:adverse effects / Q000627:therapeutic use*; D008875:Middle Aged; D010113:Oxyphenbutazone / Q000009:adverse effects / Q000627:therapeutic use*; D010919:Placebos; D013167:Spondylitis, Ankylosing / Q000188:drug therapy*
D008314:Malonates; D010919:Placebos; D010113:Oxyphenbutazone; D002118:Calcium
Bumadizon-Kalzium-Semihydrat (Eumotol) und Oxyphenbutazon zur Behandlung der Spondylitis ankylopoetica. Eine klinische Doppelblindstudie